Skip to content

Targeted Lower Extremity Joint Training

Robot-assisted Ankle Rehabilitation for Multiple Sclerosis (Anklebot)

Status
Terminated
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00765544
Enrollment
10
Registered
2008-10-03
Start date
2008-09-30
Completion date
2008-09-30
Last updated
2013-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Keywords

MS, Rehabilitation, Treadmill, Robot, Foot-drop

Brief summary

The presence of foot drop limits normal gait. Our prior data has suggested that approximately 30% of MS patients have foot drop. Although we have observed that task-specific rehabilitation using the Lokomat can improve ambulation in chronic MS patients, subjects with foot drop have difficulty translating task-specific training to normative gait patterns over ground, despite improving speed and endurance. One of the key limitations of the Lokomat is a lack of robot-assisted training for the ankle joint. The Anklebot, an MIT-developed rehabilitation robot for the ankle, has the potential to address this. The device can move throughout three planes and train ankle flexion, extension, inversion and eversion; however, therapy with the Anklebot alone does not train the knee or hip. We plan to test whether subject foot drop and overall gait benefit more from Anklebot therapy alone or a combination of Anklebot and Lokomat.

Interventions

DEVICEAnklebot

The Ankle-Bot (Wheeler et al., 2004) is a stand-alone robot assisted device that is worn via a leather boot and knee brace (Fig.1). The Ankle-Bot can assist ankle movement throughout 3 planes. The percentage of force generated by the Ankle-Bot can be adjusted from no help, 0% assistance to 100% assistance. The device is low impedance and a subject can easily over come the forces generated by the Ankle-Bot. The Ankle-Bot will guide and assist the subject into ankle flexion, extension, inversion and eversion.

DEVICELokomat

The Lokomat is a motor driven exoskeleton device that employs a body weight support suspension system and treadmill .

Sponsors

US Department of Veterans Affairs
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. Clinical diagnosis of MS by McDonald criteria (McDonald, Compston et al. 2001). EDSS level between 3.5-5.5, who report ambulation problems. 2. Men and women between the ages 18-75 years. 3. Presence of unilateral foot drop that is clinically apparent to the PI or PI designate. 4. Must be able to ambulate 25 feet without an assisting device

Exclusion criteria

1. Cardiovascular: recent MI \< 4 wk, uncontrolled HTN \>190/110 mmHg, History of uncontrolled diabetes. 2. Symptoms of orthostasis when standing up. 3. Circulatory problems, history of vascular claudication or pitting edema. 4. Unable to fully understand instructions in order to use the equipment or the process of the study. 5. Body weight over 150 kg. 6. Lower extremity injuries that limit range of motion or function. 7. Joint problems (hip or leg) that limit range of motion or cause pain with movement despite treatment. 8. Unstable fractures. 9. Pressure sores with any skin breakdown in areas in contact with the body harness or Lokomat apparatus. 10. Chronic and ongoing alcohol or drug abuse. 11. Pre-morbid, ongoing depression or psychosis. 12. Ongoing physical therapy.

Design outcomes

Primary

MeasureTime frame
Strength and Gait6 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026